Iron is a micronutrient essential for cellular energy and metabolism, necessary for
maintaining body homoeostasis. Iron deficiency is an important co-morbidity in patients with …

In patients with heart failure, iron deficiency is frequent but overlooked, with a prevalence of
30%–50%. Since it contributes to cardiac and peripheral muscle dysfunction, iron deficiency …

Iron deficiency is an extremely common comorbidity in patients with heart failure, affecting
up to 50% of all ambulatory patients. It is associated with reduced exercise capacity and …

Iron deficiency is a major heart failure co‐morbidity present in about 50% of patients with
stable heart failure irrespective of the left ventricular function. Along with compromise of daily …

Anemia and iron deficiency are important and common comorbidities that often coexist in
patients with heart failure. Both conditions, together or independently, are associated with …

Iron deficiency is present in approximately 50% of patients with symptomatic heart failure
and is independently associated with worse functional capacity, lower quality of, life and …

To date, 3 clinical trials have shown symptomatic benefit from the use of intravenous (IV) iron
in patients with heart failure (HF) with low serum iron. This has led to recommendations in …

Heart failure (HF) is highlighted by its burdening symptom-limited exercise capacity and
recurrent hospitalizations. Despite substantial advances regarding disease-modifying drugs …

Anemia and iron deficiency are common in patients with heart failure (HF), and are
associated with worse symptoms and adverse outcomes in this population. Although the two …

Growing awareness that heart failure, renal impairment, and anaemia are frequent co-
morbidities which can exacerbate one another in a vicious circle of clinical deterioration has …